Dosani Talib, Xiang Jenny, Wang Kaicheng, Deng Yanhong, Connell Nathan T, Connery Donna, Levin Forrest, Roy Alicia, Wadia Roxanne J, Wong Ellice Y, Rose Michal G
Yale School of Medicine and Yale Cancer Center, New Haven, CT.
Department of Internal Medicine, Yale School of Medicine, New Haven, CT.
JCO Oncol Pract. 2022 Apr;18(4):e564-e573. doi: 10.1200/OP.21.00420. Epub 2021 Dec 16.
Electronic consultations (e-consults) may be a valuable tool in the current era of increased demand for hematologists. Despite the increasing use of e-consults in hematology, their optimal utilization and impact on patient outcomes and workload are largely unknown.
In this retrospective cohort study, we studied the hematology consult experience at Veterans Affairs Connecticut from 2006 to 2018. We included 7,664 hematology consults (3,240 e-consults and 4,424 face-to-face [FTF] consults) requested by 1,089 unique clinicians.
We found that e-consults were rapidly adopted and used equally among physicians of different degrees of experience. The number of FTF consults did not decrease after the introduction of e-consult services. E-consults were preferentially used for milder laboratory abnormalities that had been less likely to result in a consult before their availability. Referring clinicians used e-consults preferentially for periprocedural management, anemia, leukopenia, and anticoagulation questions. Eighty-three percent of e-consults were resolved without needing an FTF visit in the year after the consult. Consults for pancytopenia, gammopathy, leukocytosis, and for patients with known malignancy were less likely to be resolved by e-consult. Among patients who were diagnosed with a new hematologic malignancy after their consult, having an e-consult before an FTF visit did not adversely affect survival.
In summary, e-consults safely expanded delivery of hematology services in our health care system but increased total consult volume. We report novel data on what types of consults may be best suited to the electronic modality, the impact of e-consults on workload, and their optimal use and implementation.
在当前血液科医生需求增加的时代,电子会诊(e-consults)可能是一种有价值的工具。尽管血液学中电子会诊的使用日益增多,但其最佳利用方式及其对患者预后和工作量的影响在很大程度上尚不清楚。
在这项回顾性队列研究中,我们研究了2006年至2018年康涅狄格州退伍军人事务部的血液科会诊经验。我们纳入了1089名不同临床医生提出的7664次血液科会诊(3240次电子会诊和4424次面对面[FTF]会诊)。
我们发现电子会诊被迅速采用,并且在不同经验程度的医生中使用情况相同。引入电子会诊服务后,面对面会诊的数量并未减少。电子会诊优先用于较轻的实验室异常情况,在其可用之前这些异常情况导致会诊的可能性较小。转诊临床医生优先将电子会诊用于围手术期管理、贫血、白细胞减少症和抗凝问题。83%的电子会诊在会诊后的一年内无需面对面就诊即可解决。全血细胞减少症、丙种球蛋白病、白细胞增多症以及已知患有恶性肿瘤患者的会诊通过电子会诊解决的可能性较小。在会诊后被诊断为新发血液系统恶性肿瘤的患者中,在面对面就诊前进行电子会诊对生存没有不利影响。
总之,电子会诊在我们的医疗保健系统中安全地扩大了血液科服务的提供,但增加了会诊总量。我们报告了关于哪些类型的会诊可能最适合电子方式、电子会诊对工作量的影响以及其最佳使用和实施的新数据。